Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. It develops ImmTAC (Immune Mobilizing Monoclonal TCRs Against Cancer) molecules, ImmTAV and ImmTAB (Immune Mobilizing Monoclonal TCRs Against Virus or Bacteria) molecules, and ImmTAAI (Immune Mobilizing Monoclonal TCRs Against Autoimmune Disease) molecules. The company uses human TCRs to overcome the limitations of a natural immune system and current therapeutic approaches through engineering bispecific.